ARCH Venture Fund IX Overage, L.P.'s Net Worth

$658 Million

Who is ARCH Venture Fund IX Overage, L.P.?

ARCH Venture Fund IX Overage, L.P. has an estimated net worth of $658 Million. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Lyell Immunopharma, Inc., Gossamer Bio, Inc., Karuna Therapeutics, Inc., Vir Biotechnology, Inc., and Beam Therapeutics Inc..

SEC CIK

ARCH Venture Fund IX Overage, L.P.'s CIK is 0001666307

Past Insider Trading and Trends

2021 was ARCH Venture Fund IX Overage, L.P.'s most active year for acquiring shares with 43 total transactions. ARCH Venture Fund IX Overage, L.P.'s most active month to acquire stocks was the month of July. 2021 was ARCH Venture Fund IX Overage, L.P.'s most active year for disposing of shares, totalling 48 transactions. ARCH Venture Fund IX Overage, L.P.'s most active month to dispose stocks was the month of January. 2019 saw ARCH Venture Fund IX Overage, L.P. paying a total of $23,200,000.00 for 39,641,007 shares, this is the most they've acquired in one year. In 2021 ARCH Venture Fund IX Overage, L.P. cashed out on 92,612,716 shares for a total of $0.00, their largest year based on trade value.